Literature DB >> 14777867

The formation of noradrenaline from dihydroxyphenylserine.

H BLASCHKO, J H BURN, H LANGEMANN.   

Abstract

Entities:  

Keywords:  ARTERENOL

Mesh：

Substances：

Year:  1950        PMID： 14777867      PMCID： PMC1509942          DOI： 10.1111/j.1476-5381.1950.tb00593.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  3 in total

1.  The activity of l(-)-dopa decarboxylase.

Authors:  H Blaschko
Journal:  J Physiol       Date:  1942-11-30       Impact factor: 5.182

2.  Adrenaline and noradrenaline in the suprarenal medulla after insulin.

Authors:  J H BURN; D E HUTCHEON; R H O PARKER
Journal:  Br J Pharmacol Chemother       Date:  1950-09

3.  Enzymic formation of noradrenaline in mammalian tissue extracts.

Authors:  K H BEYER; H BLASCHKO; J H BURN; H LANGEMANN
Journal:  Nature       Date:  1950-06-10       Impact factor: 49.962
  3 in total
  17 in total

1.  The decarboxylation of amino acids related to tyrosine and their awakening action in reserpine-treated mice.

Authors:  H BLASCHKO; T L CHRUSCIEL
Journal:  J Physiol       Date:  1960-05       Impact factor: 5.182

2.  The actions of dihydroxyphenylalanine and dihydroxyphenylserine on the sleep-wakefulness cycle of the rat after peripheral decarboxylase inhibition.

Authors:  H Altier; M Moldes; J M Monti
Journal:  Br J Pharmacol       Date:  1975-05       Impact factor: 8.739

3.  The formation in vivo of noradrenaline from 3:4-dihydroxyphenylserine (noradrenaline carboxylic acid).

Authors:  C G SCHMITERLOW
Journal:  Br J Pharmacol Chemother       Date:  1951-03

4.  Enzymes and their substrates in the adrenal gland of the ox.

Authors:  H LANGEMANN
Journal:  Br J Pharmacol Chemother       Date:  1951-06

5.  Contamination of the norepinephrine prodrug droxidopa by dihydroxyphenylacetaldehyde.

Authors:  Courtney Holmes; Noel Whittaker; Jorge Heredia-Moya; David S Goldstein
Journal:  Clin Chem       Date:  2010-03-05       Impact factor: 8.327

6.  Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?

Authors:  Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2017-06-16       Impact factor: 4.435

Review 7.  Amine precursor amino acid therapy: from neurochemical basis to clinical aspects.

Authors:  T Nakajima
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

8.  Antagonism by DL-threo-DOPS of the suppression of a conditioned avoidance response induced by a dopamine-beta-hydroxylase inhibitor.

Authors:  S Ahlenius; J Engel
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

9.  On the role of central noradrenaline in the regulation of motor activity and body temperature in the mouse.

Authors:  T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

10.  Threo-3,4-dihydroxyphenylserine, a poor source of noradrenaline in the rat.

Authors:  B L Goodwin; R D Johnson; B G Leask; C R Ruthven; M Sandler
Journal:  Experientia       Date:  1972-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.